Alastair Gray

发表

Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations

Helen Dakin, Alastair Gray, A. Gray, 2017, Statistics in medicine.

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood

Ping Zhang, Frauke Becker, Mark Lamotte, 2019, PharmacoEconomics.

Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project

John Gallacher, Andrew Turner, Jacoline C. Bouvy, 2018, Journal of Alzheimer's disease : JAD.

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge

Alan Brennan, Patrick J. O’Connor, Richard F. Pollock, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20 536 individuals

Andrew Briggs, Sarah Parish, Alastair Gray, 2005, The Lancet.

Estimating the association between SF-36 responses and EQ-5D utility values by direct mapping.

Oliver Rivero-Arias, Alastair Gray, Philip Clarke, 2004 .

Decision Making for Healthcare Resource Allocation: Joint v. Separate Decisions on Interacting Interventions

Helen Dakin, Alastair Gray, A. Gray, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62)

Alastair Gray, R. Holman, A. Gray, 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score

Helen Dakin, Alastair Gray, A. Gray, 2012, Quality of Life Research.

Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20 536 people

Andrew Briggs, Sarah Parish, Alastair Gray, 2006, BMJ : British Medical Journal.

Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.

Mark Oppe, Stavros Petrou, Louise Longworth, 2015, Journal of medical economics.

Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63)

Alastair Gray, A. Farmer, R. Holman, 2002, BMJ : British Medical Journal.

Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom

Oliver Rivero-Arias, Jane Wolstenholme, Alastair Gray, 2010, Cost effectiveness and resource allocation : C/E.

Computer Modeling of Diabetes and Its Complications

Alan Brennan, Stephen W. Sorensen, Richard Stevens, 2007, Diabetes Care.

How important is parameter uncertainty around the UK EQ-5D-3L value set when estimating treatment effects?

Jose Leal, Helen Dakin, Alastair Gray, 2012 .

Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies

Jane Wolstenholme, Rosa Legood, Alastair Gray, 2006, BMJ : British Medical Journal.

Stroke Statistics 2009

Ramon Luengo-Fernandez, Peter Scarborough, Mike Rayner, 2009 .

Cost‐effectiveness of prophylactic magnesium sulphate for 9996 women with pre‐eclampsia from 33 countries: economic evaluation of the Magpie Trial

Lelia Duley, Alastair Gray, Judit Simon, 2006, BJOG : an international journal of obstetrics and gynaecology.

Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial

Jeremy Fairbank, Oliver Rivero-Arias, Alastair Gray, 2005, BMJ : British Medical Journal.

Economic burden of cancer across the European Union: a population-based cost analysis.

Richard Sullivan, Ramon Luengo-Fernandez, Alastair Gray, 2013, The Lancet. Oncology.

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease

William Herrington, Colin Baigent, Alastair Gray, 2017, Heart.

Mapping from the Parkinson’s Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L

Emma McIntosh, Crispin Jenkinson, Alastair Gray, 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting

Stavros Petrou, Alastair Gray, A. Gray, 2011, BMJ : British Medical Journal.

Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting.

Ping Zhang, Andrew Briggs, Jacob Barhak, 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.